← Scroll for more →
Penumbra Inc (PEN)
Surgical & Medical Instruments & Apparatus
Latest Price
$318.95
TTM P/E
80.34
Normalized P/E
172.41
TTM Div Yield
--
Fwd Div Yield
--
Book Value
40.20
P/B Ratio
7.93
Valuation metrics
adjust assumptions →EPS: $4.52
Book value / share: $36.39
Formula: √(22.5 × EPS × BVPS)
Graham Number
$60.84
81% downside
Norm. op. income: $9M (median of 7yr)
Tax rate: 13%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$6.81
98% downside
Base FCF: $147M (median of recent 5yr)
Growth: 22%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$227.75
29% downside
EPS: $4.52
Target P/E: 81×
Formula: EPS × P/E
P/E Fair Value
$366.12
+14% upside
Institutional Ownership
87.9% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 4.30M | $1.36B | 10.91% | -32.9K | 2026-06-30 |
| Hbk Investments L P | 1.84M | $580.0M | 4.67% | +204.2K | 2026-06-30 |
| Vanguard Capital Management LLC | 1.71M | $539.0M | 4.34% | +15.4K | 2026-06-30 |
| Vanguard Portfolio Management LLC | 1.67M | $526.0M | 4.23% | +12.8K | 2026-06-30 |
| State Street Corp | 1.24M | $392.0M | 3.16% | +57.4K | 2026-06-30 |
| ExodusPoint Capital Management, LP | 1.09M | $344.0M | 2.77% | +625.2K | 2026-06-30 |
| Balyasny Asset Management L.P. | 1.09M | $344.0M | 2.77% | +328.1K | 2026-06-30 |
| JPMorgan Chase & Co | 1.07M | $338.0M | 2.72% | +274.0K | 2026-06-30 |
| Millennium Management LLC | 947.6K | $299.0M | 2.40% | -198.5K | 2026-06-30 |
| Goldman Sachs Group Inc | 856.8K | $270.0M | 2.17% | +136.2K | 2026-06-30 |